(BHVN) – Mergers and Acquisitions
-
Biohaven Pharma (BHVN) Acquires Exclusive License for Oral, Brain-Penetrant, Dual TYK2/JAK1 Inhibitor for Immune-Mediated Brain Disorders
-
Pfizer (PFE) Completes Acquisition of Biohaven Pharmaceuticals
-
-
-
-
-
-
-
-
-
-
Back to BHVN Stock Lookup